Search Orphan Drug Designations and Approvals
-
Generic Name: | 3-(5-Fluoro-benzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)-pyrrole-2,5-dione |
---|---|
Date Designated: | 03/29/2016 |
Orphan Designation: | Treatment of glioblastoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Actuate Therapeutics 1751 River Run Suite 400 Fort Worth, Texas 76107 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-